查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1435767

無菌醫療包裝：市場佔有率分析、產業趨勢與統計、成長預測（2024-2029）

Sterile Medical Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

無菌醫療包裝市場規模預計2024年為637.7億美元，預計到2029年將達到967.2億美元，在預測期（2024-2029年）將成長8.69%，複合年成長率成長。

無菌醫療包裝 - 市場

主要亮點

  • 流行病和大流行病構成的威脅日益明顯，成為一項持續的普遍挑戰，現已被認為是全球衛生議程中行動的重中之重。各種組織針對感染預防和控制（IPC）制定了嚴格的規定，預計將增加對無菌醫療包裝、無污染醫療產品和預防疾病傳播的需求。由於這些規定，Jubilant HollisterStie 等公司正在投資擴大產能。 2022 年 5 月，Jubilant HollisterStier 投資 2.85 億美元，將其華盛頓州斯波坎工廠的無菌注射劑填充和精加工產能提高了一倍。這項投資是該公司合作協議的一部分，美國政府將為其提供 1.496 億美元，以擴大其在美國的關鍵疫苗生產能力。
  • 此外，該供應商正在不斷擴大其業務，以擴大產品系列。例如，通過 ISO 9001:2015 認證的 Dordan Manufacturing Inc. 啟動了無塵室計劃，以增強其在醫療包裝方面的現有專業知識。該公司為多個行業設計、製造和銷售客自訂熱成型包裝。
  • 醫用無菌包裝對於醫療保健和感染疾病控制至關重要。無菌醫療包裝不斷創新，並投資於一次性選擇和生物分解性塑膠，且無污染風險。這些包裝可保護患者、醫務人員和臨床醫生免受潛在的微生物感染。它還有助於確保醫療產品在運輸、儲存和使用過程中無菌且不受污染。
  • 近年來，聚碳酸酯、聚丙烯和聚乙烯等許多聚合物作為材料被廣泛應用於醫療包裝產業。然而，高性能塑膠和工程聚合物的進步日益滲透到該行業，取代了傳統金屬和現有的一般塑膠，這主要是由於刺激性強的消毒劑的出現。 2022 年 9 月，英國科學家開發出一種塑膠薄膜，僅使用室內光即可殺死附著在表面的 SARS-CoV-2 病毒顆粒。這種自消毒薄膜由英國貝爾法斯特女王大學的一個團隊開發，製造成本低廉且易於規模化。用於桌布、醫院窗簾、一次性圍裙等。該薄膜塗有一層薄薄的顆粒，可吸收紫外線 (UV) 並產生活性氧 (ROS)，預計將取代醫療保健行業使用的一次性塑膠薄膜。
  • 然而，在歐洲國家，歐盟法規要求各藥品生產商在供應歐盟產品時必須遵守歐盟良好生產規範（GMP）。此外，製造商和進口商必須獲得許可證並向成員國主管機關機關注冊。製造商和進口商定期接受歐盟主管機關或其他認可機構的檢查，以確保符合歐盟的 GMP。無論製造商位於何處，此過程均適用。如果產品是從其他公司進口的，則進口商有責任遵守 GMP。
  • 此外，在全球冠狀病毒感染疾病（COVID-19）大流行期間，供應鏈中斷導致無菌包裝製造業下滑。相較之下，消費者對病毒接觸各種物質的擔憂不斷增加，將推動產業成長。疫情期間，快速生產也成為醫療包裝專業人士的關鍵因素。越來越多的醫療保健公司需要更快、更永續的包裝，自感染疾病-19 以來，包裝公司正在竭盡全力滿足這項需求。

無菌醫療包裝市場趨勢

管瓶和安瓿預計將佔據很大佔有率

  • 無菌醫療包裝主要包括管瓶和安瓿。它們廣泛應用於製藥業，用於填充和儲存各種藥品和藥品。所有化學不穩定物質、藥物和化學物質都可以儲存在這些物品中。這些有助於防止篡改存放在那裡的藥物和其他物品。任何含有藥物或藥物的樣本都可以長期保存在管瓶中。
  • 過去幾年，與 COVID-19感染疾病相關的藥品和疫苗的需求增加了對管瓶和安瓿的需求。藥品包裝製造商顯著提高了產能。製造商滿載運作，每月生產數百萬管瓶和安瓿。
  • 該行業的領先公司致力於透過投資和合作夥伴關係進行擴張。例如，2022年8月，德國藥品包裝供應商Gerresheimer宣布投資高達9,400萬美元，以加強其在美國的管瓶製造、出貨和分銷能力。該公司計劃在其北卡羅來納州工廠增加管瓶成型生產線，以進行擴建計劃。其中包括尺寸控制、退火、目視檢查和包裝線。
  • 玻璃是常用於製造管瓶和安瓿的材料之一。除了醫療保健成本上升之外，藥品銷售的增加以及包括醫院和製藥公司在內的各種最終用戶的成長趨勢，導致對化學惰性和藥物穩定性以及管瓶和安瓿包裝的需求增加。滲透性將促進玻璃瓶和安瓿瓶的使用。這些項目。液體和凍乾藥物。此外，根據Astra Zeneca，美國藥品銷售額與前一年同期比較增約 8%，從 2020 年的 5,160 億美元增至 2022 年的 6,050 億美元。
  • 此外，在人口稠密的國家，對管瓶和安瓿的需求正在增加。這些國家藥品生產的增加進一步增加了需求。根據成分和藥物含量等參數，應包裝在非反應性容器中。生物製藥、疫苗和胰島素的消費量不斷增加，特別是在亞太地區、拉丁美洲和東歐國家，預計在預測期內推動安瓿使用量的成長。

預計北美將出現顯著成長。

  • 該地區的已開發國家，如美國和加拿大，擁有繁榮的經濟、人口老化和先進的醫療保健服務系統。美國擁有發達的基層醫療社區、廣泛的醫療和生命科學研究活動、較高的醫療保健支出集中、豐富的藥品和醫療用品及醫療設備產業，是全球最大的無菌醫療包裝產品生產國，已成為世界上最大的無菌醫療包裝產品生產國。市場。這是我們主要的地理市場之一。
  • 醫療技術的高昂醫療成本正在推動對美國無菌醫療包裝市場的需求。醫學技術的進步使醫生能夠以以前難以治療的方式診斷和治療疾病。醫療技術方面醫療保健支出的增加可能會將新的醫療設備和產品推向市場。隨著設備和產品的可用性、數量和種類的增加，對無菌醫療包裝的需求也增加。
  • 國際公司正在向該地區擴張。 2023 年 3 月，Granules India 透過其位於美國維吉尼亞的 Granules Consumer Health (GCH) 子公司推出了一家包裝工廠。該工廠佔地超過 79,000 平方英尺，包括包裝線和無塵室，用於包裝和出貨處方箋和非處方產品到整個美國市場。該設施以 483 個零觀測值獲得美國FDA核准。
  • 製藥業對無菌醫療包裝產品的需求不斷成長，預計將在預測期內進一步推動所研究市場的成長。據StatCan稱，預計2024年製藥和藥品製造業的收益將達到99.4億美元。
  • 此外，加拿大對注射藥物的需求不斷成長正在推動玻璃瓶的成長。對腫瘤學和其他強效藥物（例如需要快速起效的類固醇、靜脈靜脈注射和抗體偶聯物）的需求預計將成為主要的成長動力。此外，Hikma Pharmaceuticals PLC 等跨國公司正致力於在該地區推出無菌注射藥物。 2023年3月，跨國藥廠Hikma Pharmaceuticals PLC（Hikma）宣佈在加拿大推出四種新的無菌注射藥物。這擴大了該公司在加拿大市場的影響力，並為患者和醫療保健提供者提供了新的治療選擇。

無菌醫療包裝產業概況

由於國內和國際市場上的大大小小的參與者，無菌醫療包裝市場競爭非常激烈。市場參與者正在採取產品創新、併購和策略合作夥伴關係等關鍵策略，以擴大產品系列擴大其地理覆蓋範圍。市場參與者包括 Amcor PLC、Steripack Ltd、Wipak Group 和 Placon Corporation。

2022 年 5 月，這家美國包裝公司的子公司無塵室 Film and Bags (CFB) 開設了一家生產無菌無塵室包裝的工廠。該設施擁有 ISO 認證的無塵室，並使用太陽能。

2022 年 4 月，Amcor 擴建了位於愛爾蘭斯萊戈的醫療保健包裝工廠，以鞏固其在無菌包裝行業的地位。作為計劃的一部分，Amcor 將增加 VII 級無塵室製造環境和先進的熱成型操作，該操作已通過 ISO 13485 認證，以滿足監管要求。

其他福利

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 產業吸引力－波特五力分析
    • 新進入者的威脅
    • 買方議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度
  • 產業價值鏈分析
  • 評估 COVID-19 對無菌醫療包裝市場的影響

第5章市場動態

  • 市場促進因素
    • 嚴格的感染控制法規預計將推動對無菌產品的需求
    • 最近產能增加
    • 塑膠領域材料的進展
  • 市場挑戰
    • 法規的動態性質使得製造商很難遵守與材料可用性相關的區域因素

第6章市場區隔

  • 依材料類型
    • 塑膠
      • 聚丙烯
      • 聚酯纖維
      • PS
      • PVC、HDPE 等
    • 紙板
    • 玻璃
    • 其他
  • 依產品類型
    • 熱成型托盤
    • 無菌瓶/容器
    • 袋子和袋子
    • 泡殼包裝
    • 管瓶和安瓿
    • 預填充式注射器
    • 裹
  • 按用途
    • 藥品
    • 手術和醫療器械
    • 體外診斷藥物
    • 其他用途
  • 按滅菌類型
    • 化學滅菌
    • 放射線殺菌
    • 壓力/溫度滅菌
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第7章 競爭形勢

  • 公司簡介
    • Amcor PLC
    • Dupont De Nemours Inc.
    • Steripack Ltd
    • Wipak Group
    • Placon Corporation
    • Riverside Medical Packaging Company Ltd
    • Tekni-Plex Inc.
    • BillerudKorsnas AB
    • Sonoco Products Co
    • Wheaton Industries
    • Technipaq Inc.
    • 3M Co（3M Packaging）
    • Nelipak Healthcare

第8章市場展望

簡介目錄
Product Code: 69033

The Sterile Medical Packaging Market size is estimated at USD 63.77 billion in 2024, and is expected to reach USD 96.72 billion by 2029, growing at a CAGR of 8.69% during the forecast period (2024-2029).

Sterile Medical Packaging - Market

Key Highlights

  • The threats posed by epidemics and pandemics have become increasingly evident as ongoing universal challenges, and they are now recognized as a top priority for action on the global health agenda. Various organizations have put up strict regulations toward infection prevention and control (IPC), which is expected to drive the demand for sterile-based medical packaging, contamination-free medical products, and preventing disease transmission. Owing to such regulation, a player such as Jubilant HollisterStie is investing in expanding capacity. In May 2022, Jubilant HollisterStier invested USD 285 million to double its capacity to fill and finish sterile injectables at its Spokane, Washington facility. The investment is part of the company's cooperative agreement providing USD 149.6 million from the US Government to expand its critical vaccine manufacturing capacity in the US.
  • Additionally, vendors are continuously expanding their operations to widen their product portfolio. For instance, Dordan Manufacturing Inc. (an ISO 9001:2015 certified company) initiated its cleanroom project to enhance its existing expertise in medical packaging. The company designs, manufactures and distributes custom thermoformed packaging for multiple industries.
  • Sterile medical packaging is integral to healthcare and infectious disease control. Sterile medical packaging continues to innovate and invest in single-use options and biodegradable plastics without the risk of contamination. These packagings protect patients, medical staff, and clinicians from potential microbial infections. It also helps ensure that medical products are sterile and uncontaminated during transportation, storage, and use.
  • In the past few years, many polymers, such as polycarbonates, polypropylene, and polyethene, have been widely adopted as a material of choice by the medical packaging industry. However, high-performance advancements in plastic and engineering polymers have seen growing penetration in the industry, replacing conventional metals and existing commodity plastics primarily because of the advent of stringent and robust sanitizing agents. In September 2022, Scientists in the UK developed a plastic film that can kill SARS-CoV-2 virus particles attached to its surface with just room light. Developed by a team at Queen's University Belfast in the UK, the self-sterilizing film is cheap to manufacture and easy to scale. It is used in tablecloths, curtains in hospitals, and disposable aprons. The film is coated with a thin layer of particles that absorb ultraviolet (UV) light and generate reactive oxygen species - ROS and is expected to replace disposable plastic films used in the healthcare industry.
  • However, In European countries, EU regulations require that various pharmaceutical manufacturers comply with EU Good Manufacturing Practices (GMP) when supplying products to the EU. In addition, manufacturers and importers must be licensed and registered by the competent authorities of Member States. Manufacturers and importers are regularly inspected by their EU authorities in the jurisdiction or other recognized authorities to confirm compliance with their GMPs in the EU. This process applies regardless of the manufacturer's location. If the product is imported from another company, the importer is responsible for GMP compliance.
  • Furthermore, disruptions in the supply chain contributed to a downfall in manufacturing sterile packaging amid the global COVID-19 pandemic. In contrast, rising consumer concerns associated with viral exposure to various materials favour the industry's growth. Also, rapid production has become a key factor for medical packaging professionals during the pandemic. More medical companies are demanding faster and more sustainable packaging, and packaging companies are overdriving to meet that demand post-COVID-19.

Sterile Medical Packaging Market Trends

Vials and Ampoules is Expected to Hold a Significant Share

  • Sterile medical packaging mainly includes vials and ampoules. They are widely used in the pharmaceutical business to fill and store a variety of medications and pharmaceuticals. Chemically unstable materials, drugs, and chemicals can all be stored in these items. These aid in preventing tampering with medicines and other things kept there. Every sample, including medications and drugs, can be kept longer in vials.
  • The demand for vials and ampoules has grown due to the medications and vaccination demand related to the COVID-19 pandemic in the past few years. Manufacturers of pharmaceutical packaging have significantly boosted their production capacity. Millions of vials and ampoules are produced monthly by manufacturers operating at full capacity.
  • Major companies operating in the industry are focused on expansions through investments and collaborations. For instance, in August 2022, German pharmaceutical packaging supplier Gerresheimer announced an investment of up to USD 94 million to strengthen its glass vial manufacturing, shipping, and distribution capabilities in the United States. The company will add a vial forming line to its North Carolina facility for the expansion project. These include dimensional control, annealing, visual inspection, and packaging lines.
  • Glass is one of the materials that is frequently used to make vials and ampoules. The increasing healthcare expenditures, along with growing pharmaceutical sales and the expanding propensity of various end-users, including hospitals and pharmaceutical businesses, would propel the use of the items due to their chemical inertness and impermeability to drug stability, glass vials, and ampoules package liquid and lyophilized medications. Further, according to AstraZeneca, pharmaceutical sales in the United States are growing by ~8% year-on-year and have reached USD 605 billion in 2022 from USD 516 billion in 2020.
  • Further, there is an increasing demand for vials and ampoules in nations with dense populations. The rising pharmaceutical manufacturing in these nations is further fueling the need. Depending on parameters, such as the ingredients and medication content, they must be packaged in a nonreactive container. Increased consumption of biopharmaceuticals, vaccines, and insulin, particularly in nations in the Asia-Pacific, Latin America, and Eastern Europe, is projected to encourage a rise in the usage of ampoules during the forecast period.

North America is Expected to Witness a Significant Growth.

  • The developed countries in the region, such as the United States and Canada, have prosperous economies, ageing populations, and advanced medical delivery systems. With its advanced primary care community, extensive medical and life sciences research activities, high healthcare spending intensity, and ample pharmaceutical and medical supplies and medical device industries, the United States is the world's largest market for sterile medical packaging products. It is one of our important geographical markets.
  • High medical spending on medical technology drives the demand for the sterile medical packaging market in the United States. Technological advancements in medicine have enabled doctors to diagnose and treat diseases in previously difficult ways. Increased medical spending on medical technology may bring new medical devices and products to market. As the availability, number, and variety of devices and products increase, so does the demand for sterile medical packaging.
  • International companies are expanding their business into the region. In March 2023, Granules India launched its packaging facility through its Granules Consumer Health (GCH) step-down subsidiary, which is located in Virginia, US. The facility is over 79,000 square feet and is equipped with packaging lines and clean rooms to package and ship prescription and over-the-counter products across the U.S. market. The facility received US FDA approval with zero 483 observations.
  • The increasing demand for sterile medical packaging products from pharmaceutical industries would further drive the growth of the studied market during the projected timeframe. According to StatCan, in 2024, pharmaceutical and medicine manufacturing industry revenue is expected to account for USD 9.94 billion.
  • Moreover, the increasing demand for injectable pharmaceuticals in Canada is driving the growth of glass bottles. The need for oncology and other high-potency drugs (such as steroids, IV fluids, and antibody conjugates that require quick onset of action) is anticipated to be the key growth driver. In addition, global players, such as Hikma Pharmaceuticals PLC, are focusing on launching sterile injectable medicines in the region. In March 2023, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, announced the launch of four new sterile injectable drugs in Canada, providing new treatment options for patients and healthcare service providers alongside building on the company's growing presence in the Canadian market.

Sterile Medical Packaging Industry Overview

The Sterile Medical Packaging Market is highly competitive, owing to several small and large players operating in domestic and international markets. The players in the market are adopting major strategies, like product innovations, mergers and acquisitions, and strategic partnerships, to widen their product portfolio and expand their geographical reach. Some of the players in the market are Amcor PLC, Steripack Ltd, Wipak Group, and Placon Corporation, among others.

In May 2022, Cleanroom Film and Bags (CFB), a division of a US-based packaging company, opened a facility to manufacture sterile cleanroom packaging. The facility features ISO-certified cleanrooms and will use solar-powered energy.

In April 2022, Amcor expanded its healthcare packaging facility in Sligo, Ireland, to strengthen its position in the sterile packaging industry. As part of the project, Amcor will add Class VII cleanroom manufacturing environments and ISO 13485-certified advanced thermoforming operations that meet regulatory requirements.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.2.1 Threat of New Entrants
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Bargaining Power of Suppliers
    • 4.2.4 Threat of Substitute Products
    • 4.2.5 Intensity of Competitive Rivalry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Assessment of the Impact of COVID-19 on the Sterile Medical Packaging Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Stringent regulations towards infection control expected to aid demand for sterile-based products
    • 5.1.2 Recent increase in utilization capacity
    • 5.1.3 Material advancements in the field of Plastics
  • 5.2 Market Challenges
    • 5.2.1 Dynamic nature of regulations makes it challenging for manufacturers to comply with local factors with issues related to material availability

6 MARKET SEGMENTATION

  • 6.1 By Material Type
    • 6.1.1 Plastic
      • 6.1.1.1 PP
      • 6.1.1.2 Polyester
      • 6.1.1.3 PS
      • 6.1.1.4 PVC, HDPE, etc.
    • 6.1.2 Paper and Paperboard
    • 6.1.3 Glass
    • 6.1.4 Others
  • 6.2 By Product Type
    • 6.2.1 Thermoform Trays
    • 6.2.2 Sterile Bottles and Containers
    • 6.2.3 Pouches and Bags
    • 6.2.4 Blisters Packs
    • 6.2.5 Vials and Ampoules
    • 6.2.6 Pre-Filled Syringes
    • 6.2.7 Wraps
  • 6.3 By Application Type
    • 6.3.1 Pharmaceutical
    • 6.3.2 Surgical and Medical Appliances
    • 6.3.3 IVD
    • 6.3.4 Other Applications
  • 6.4 By Sterilization Type
    • 6.4.1 Chemical Sterilization
    • 6.4.2 Radiation Sterilization
    • 6.4.3 Pressure/Temperature Sterilization
  • 6.5 By Geography
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia Pacific
    • 6.5.4 Rest of the World

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Amcor PLC
    • 7.1.2 Dupont De Nemours Inc.
    • 7.1.3 Steripack Ltd
    • 7.1.4 Wipak Group
    • 7.1.5 Placon Corporation
    • 7.1.6 Riverside Medical Packaging Company Ltd
    • 7.1.7 Tekni-Plex Inc.
    • 7.1.8 BillerudKorsnas AB
    • 7.1.9 Sonoco Products Co
    • 7.1.10 Wheaton Industries
    • 7.1.11 Technipaq Inc.
    • 7.1.12 3M Co (3M Packaging)
    • 7.1.13 Nelipak Healthcare

8 MARKET OUTLOOK